Follicular Lymphoma
Conference Coverage
VIDEO: CAR T cell axi-cel drives B-cell lymphomas into remission
Dr. Sattva S. Neelapu describes efforts to manage adverse events common to CAR T-cell therapies, notably cytokine release syndrome.
Conference Coverage
Updated ZUMA-1 data show durable CAR-T responses in B-cell lymphomas
ATLANTA – Updated results in 108 patients with refractory B cell lymphomas showed an ORR of 82%, including 58% complete responses, after a median...
Conference Coverage
ASCT or novel therapies in early relapsing follicular lymphoma?
NEW YORK – Should autologous stem cell transplantation or novel therapies be the next step when a patient with follicular lymphoma experiences...
Conference Coverage
Marginal zone lymphoma treatment studies to be presented at ASH
Several studies will focus on combination treatment approaches in MZL.
Conference Coverage
CAR T-cells gain ground against hematologic cancers
New data from the ZUMA-1 and JULIET studies will be presented at ASH 2017.
News
Method identifies effective treatments for leukemias, lymphomas
An ex vivo drug screening method can reveal optimal therapies for patients with hematologic malignancies, according to research published in The...
News
FDA approves obinutuzumab for follicular lymphoma
Approval is based on a 28% lower risk of disease progression or death after 2 years for patients on the obinutuzumab-based regimen.
Conference Coverage
Debate: Is MRD ready for prime time in multiple myeloma?
NEW YORK – Two leading multiple myeloma experts question whether it’s time to incorporate minimal residual disease measures into daily practice....
Conference Coverage
Is MRD ready for prime time in multiple myeloma?
NEW YORK, NY—Speakers faced off over the issue of minimal residual disease (MRD) testing in multiple myeloma (MM) at Lymphoma & Myeloma 2017....
News
EMA recommends orphan designation for G100 to treat FL
The European Medicines Agency’s (EMA’s) Committee for Orphan Medicinal Products has recommended orphan designation for G100 for the treatment of...